DE3781488D1 - Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten. - Google Patents

Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.

Info

Publication number
DE3781488D1
DE3781488D1 DE8787113638T DE3781488T DE3781488D1 DE 3781488 D1 DE3781488 D1 DE 3781488D1 DE 8787113638 T DE8787113638 T DE 8787113638T DE 3781488 T DE3781488 T DE 3781488T DE 3781488 D1 DE3781488 D1 DE 3781488D1
Authority
DE
Germany
Prior art keywords
dideoxycytidin
retrovirus
pharmaceutical composition
didehydrocytidine
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787113638T
Other languages
English (en)
Other versions
DE3781488T2 (de
Inventor
Tai-Shun Lin
William H Prusoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Application granted granted Critical
Publication of DE3781488D1 publication Critical patent/DE3781488D1/de
Publication of DE3781488T2 publication Critical patent/DE3781488T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787113638T 1986-09-24 1987-09-17 Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten. Expired - Fee Related DE3781488T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91120086A 1986-09-24 1986-09-24

Publications (2)

Publication Number Publication Date
DE3781488D1 true DE3781488D1 (de) 1992-10-08
DE3781488T2 DE3781488T2 (de) 1993-02-18

Family

ID=25429894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787113638T Expired - Fee Related DE3781488T2 (de) 1986-09-24 1987-09-17 Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.

Country Status (18)

Country Link
EP (1) EP0261595B1 (de)
JP (2) JPH078796B2 (de)
KR (1) KR960001372B1 (de)
AT (1) ATE80039T1 (de)
AU (1) AU596864B2 (de)
CA (1) CA1304360C (de)
DE (1) DE3781488T2 (de)
DK (1) DK462687A (de)
EG (1) EG18441A (de)
ES (1) ES2052533T3 (de)
FI (1) FI874166A (de)
GR (1) GR3005870T3 (de)
IE (1) IE62103B1 (de)
IL (1) IL83944A (de)
NZ (1) NZ221893A (de)
PH (1) PH22990A (de)
PT (1) PT85755B (de)
ZA (1) ZA876411B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116822A (en) * 1986-10-24 1992-05-26 Stichting Rega Vzw Therapeutic application of dideoxycytidinene
JPS63107924A (ja) * 1986-10-25 1988-05-12 Yamasa Shoyu Co Ltd 抗レトロウイルス剤
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
JPH02152976A (ja) * 1988-05-06 1990-06-12 Bristol Myers Co ２´，３´―ジデヒドロ―２´，３´―ジデオキシヌクレオシドのプロドラッグ
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
EP0355031A3 (de) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69207656T2 (de) * 1991-01-30 1996-10-17 Wellcome Found Wasserlösliche tabletten
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
ATE284894T1 (de) * 1994-10-24 2005-01-15 Genencor Int L-pyranosyl-nukleoside
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
FR2528311B1 (fr) * 1982-06-14 1985-06-14 Synthelabo Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
WO1987001283A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxycytidine
EP0258412A1 (de) * 1986-02-20 1988-03-09 GREER, Sheldon B. Zubereitung und verfahren zur behandlung von aids und verwandten krankheiten

Also Published As

Publication number Publication date
IE62103B1 (en) 1994-12-14
ES2052533T3 (es) 1994-07-16
JPH078796B2 (ja) 1995-02-01
JPH0818986B2 (ja) 1996-02-28
PH22990A (en) 1989-02-24
DK462687A (da) 1988-03-25
IL83944A0 (en) 1988-02-29
ATE80039T1 (de) 1992-09-15
GR3005870T3 (de) 1993-06-07
IE872562L (en) 1988-03-24
DE3781488T2 (de) 1993-02-18
JPH07145058A (ja) 1995-06-06
AU596864B2 (en) 1990-05-17
DK462687D0 (da) 1987-09-04
PT85755B (pt) 1990-08-31
KR960001372B1 (ko) 1996-01-26
KR880003626A (ko) 1988-05-28
CA1304360C (en) 1992-06-30
EP0261595B1 (de) 1992-09-02
FI874166A (fi) 1988-03-25
IL83944A (en) 1993-01-31
EP0261595A3 (en) 1990-01-24
AU7797787A (en) 1988-03-31
PT85755A (en) 1987-10-01
ZA876411B (en) 1988-03-18
NZ221893A (en) 1990-11-27
EG18441A (en) 1992-12-30
FI874166A0 (fi) 1987-09-23
JPS63146822A (ja) 1988-06-18
EP0261595A2 (de) 1988-03-30

Similar Documents

Publication Publication Date Title
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
DE3781488T2 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DE3780016T2 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
IT8611760V0 (it) Siringa per l'anestesia intraligamentosa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee